Nexgen Pharma, Inc   Report issue

For profit Phase 1 Phase 2
Founded: Irvine CA United States (1925)
Status: Acquired by LGM Pharma (2020)

Organization Overview

First Clinical Trial
2008
NCT01183910
First Marketed Drug
1972
propoxyphene (Darvon)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Nexgen Dermatologics, Inc. | NEXGEN PHARMA | NEXGEN PHARMA INC